Dian Diagnostics Group Co Ltd
SZSE:300244

Watchlist Manager
Dian Diagnostics Group Co Ltd Logo
Dian Diagnostics Group Co Ltd
SZSE:300244
Watchlist
Price: 12.39 CNY -6.49% Market Closed
Market Cap: 7.8B CNY
Have any thoughts about
Dian Diagnostics Group Co Ltd?
Write Note

Net Margin
Dian Diagnostics Group Co Ltd

-0.8%
Current
5%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-0.8%
=
Net Income
-92.6m
/
Revenue
12.4B

Net Margin Across Competitors

Country CN
Market Cap 7.8B CNY
Net Margin
-1%
Country US
Market Cap 91.8B USD
Net Margin
1%
Country US
Market Cap 87.7B EUR
Net Margin
1%
Country US
Market Cap 73B USD
Net Margin
1%
Country DE
Market Cap 24.9B EUR
Net Margin
3%
Country US
Market Cap 20.1B USD
Net Margin
3%
Country DE
Market Cap 18.8B EUR
Net Margin
-2%
Country US
Market Cap 18.3B USD
Net Margin
9%
Country US
Market Cap 13.7B USD
Net Margin
7%
Country DE
Market Cap 12.4B EUR
Net Margin
3%
Country AU
Market Cap 13.4B AUD
Net Margin
6%
No Stocks Found

Dian Diagnostics Group Co Ltd
Glance View

Market Cap
7.8B CNY
Industry
Health Care

Dian Diagnostics Group Co. Ltd. engages in the sale, outsourcing, research and development of medical diagnostic product and services. The company is headquartered in Hangzhou, Zhejiang and currently employs 11,123 full-time employees. The company went IPO on 2011-07-19. The firm's main business involves inspection services, product services, health management, judicial expertise, contract research organization (CRO), cold chain logistics and other fields. The firm's business is mainly oriented to medical and health institutions at all levels, such as various general and specialized hospitals, community health service centers, township (town) health centers, physical examination centers, disease prevention and control centers, etc. The firm's products include Atomic Bomb in the field of liquid phase mass spectrometry, Hydrogen Bomb in the field of nucleic acid mass spectrometry, and Man-Made Satellite in the field of pathological diagnosis products and molecular diagnosis products, and others.

Intrinsic Value
25.84 CNY
Undervaluation 52%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-0.8%
=
Net Income
-92.6m
/
Revenue
12.4B
What is the Net Margin of Dian Diagnostics Group Co Ltd?

Based on Dian Diagnostics Group Co Ltd's most recent financial statements, the company has Net Margin of -0.8%.